370 related articles for article (PubMed ID: 29310703)
1. Management of Persistent Epistaxis Using Floseal Hemostatic Matrix vs. traditional nasal packing: a prospective randomized control trial.
Murray S; Mendez A; Hopkins A; El-Hakim H; Jeffery CC; Côté DWJ
J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):3. PubMed ID: 29310703
[TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis.
Mathiasen RA; Cruz RM
Laryngoscope; 2005 May; 115(5):899-902. PubMed ID: 15867662
[TBL] [Abstract][Full Text] [Related]
3. FloSeal hemostatic matrix in persistent epistaxis: prospective clinical trial.
Côté D; Barber B; Diamond C; Wright E
J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):304-8. PubMed ID: 20470677
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of floseal compared to nasal packing for the management of anterior epistaxis.
Le A; Thavorn K; Lasso A; Kilty SJ
Laryngoscope; 2018 Aug; 128(8):1778-1782. PubMed ID: 29314035
[TBL] [Abstract][Full Text] [Related]
5. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
6. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).
Lee JM; Wu V; Faughnan ME; Lasso A; Figol A; Kilty SJ
J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):48. PubMed ID: 31615556
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the use of Floseal haemostatic matrix in the treatment of epistaxis: a prospective, control-matched longitudinal study.
Lau AS; Upile NS; Lazarova L; Swift AC
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2579-84. PubMed ID: 26920703
[TBL] [Abstract][Full Text] [Related]
8. The utility of FloSeal haemostatic agent in the management of epistaxis.
Khan MK; Reda El Badawey M; Powell J; Idris M
J Laryngol Otol; 2015 Apr; 129(4):353-7. PubMed ID: 25776997
[TBL] [Abstract][Full Text] [Related]
9. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
[TBL] [Abstract][Full Text] [Related]
10. [Hemostatic absorbable gel matrix for severe post-traumatic epistaxis].
Bachelet JT; Bourlet J; Gleizal A
Rev Stomatol Chir Maxillofac Chir Orale; 2013 Nov; 114(5):310-4. PubMed ID: 24028779
[TBL] [Abstract][Full Text] [Related]
11. Prospective, randomized, controlled trial of a hemostatic sealant in children undergoing adenotonsillectomy.
Jo SH; Mathiasen RA; Gurushanthaiah D
Otolaryngol Head Neck Surg; 2007 Sep; 137(3):454-8. PubMed ID: 17765775
[TBL] [Abstract][Full Text] [Related]
12. The use of FloSeal haemostatic sealant in the management of epistaxis: a prospective clinical study and literature review.
Wakelam OC; Dimitriadis PA; Stephens J
Ann R Coll Surg Engl; 2017 Jan; 99(1):28-30. PubMed ID: 27490981
[TBL] [Abstract][Full Text] [Related]
13. Similar patient outcomes yet different hospital costs between flowable hemostatic agents.
David G; Lim S; Gunnarsson C; Kocharian R; Roy S
J Med Econ; 2015; 18(9):735-45. PubMed ID: 25907200
[TBL] [Abstract][Full Text] [Related]
14. The effect of FloSeal on mucosal healing after endoscopic sinus surgery: a comparison with thrombin-soaked gelatin foam.
Chandra RK; Conley DB; Kern RC
Am J Rhinol; 2003; 17(1):51-5. PubMed ID: 12693656
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of a Thrombin-Containing Collagen-Based Hemostatic Agent in Spinal Surgery: A Randomized Clinical Trial.
Park SM; Kang DR; Lee JH; Jeong YH; Shin DA; Yi S; Ha Y; Kim KN
World Neurosurg; 2021 Oct; 154():e215-e221. PubMed ID: 34246825
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of hemostatic gelatin sponge as a packing material after septoplasty: A prospective, randomized, multicenter study.
Kim SD; Hong SL; Kim MJ; Kim JY; Kim YW; Koo SK; Cho KS
Auris Nasus Larynx; 2018 Apr; 45(2):286-290. PubMed ID: 28552274
[TBL] [Abstract][Full Text] [Related]
17. A Gelatin-Thrombin Matrix Topical Hemostatic Agent (Floseal) in Combination With Harmonic Scalpel Is Effective in Patients Undergoing Total Thyroidectomy: A Prospective, Multicenter, Single-Blind, Randomized Controlled Trial.
Docimo G; Tolone S; Conzo G; Limongelli P; Del Genio G; Parmeggiani D; De Palma M; Lupone G; Avenia N; Lucchini R; Monacelli M; Gulotta G; Scerrino G; Pasquali D; Bellastella G; Esposito K; De Bellis A; Pezzolla A; Ruggiero R; Docimo L
Surg Innov; 2016 Feb; 23(1):23-9. PubMed ID: 26243629
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of a thrombin-based hemostatic agent in unilateral total knee arthroplasty: a randomized controlled trial.
Kim HJ; Fraser MR; Kahn B; Lyman S; Figgie MP
J Bone Joint Surg Am; 2012 Jul; 94(13):1160-5. PubMed ID: 22623075
[TBL] [Abstract][Full Text] [Related]
19. Use of floseal hemostatic matrix for control of hemostasis during laparoscopic cholecystectomy for acute cholecystitis: a multicenter historical control group comparison (the GLA study gelatin matrix for acute cholecystitis).
Sartelli M; Catena F; Biancafarina A; Tranà C; Piccardo A; Ceccarelli G; Tirone G; Agresta F; Di Giorgio A; Catani M; Tricarico F; Buonanno M; Piazza L
J Laparoendosc Adv Surg Tech A; 2014 Dec; 24(12):837-41. PubMed ID: 25025393
[TBL] [Abstract][Full Text] [Related]
20. Use of a novel topical hemostatic sealant in lacrimal surgery: a prospective, comparative study.
Durrani OM; Fernando AI; Reuser TQ
Ophthalmic Plast Reconstr Surg; 2007; 23(1):25-7. PubMed ID: 17237685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
